Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ADORA3 | P0DMS8 | 4/20 | 0.47 |
| ▸ | ABCB1 | P08183 | 1/20 | 0.45 |
| ▸ | ELANE | P08246 | 5/20 | 0.43 |
| ▸ | ALOX5 | P09917 | 2/20 | 0.43 |
| ▸ | FFAR1 | O14842 | 1/20 | 0.41 |
| ▸ | PLA2G2A | P14555 | 1/20 | 0.41 |
| ▸ | PLA2G5 | P39877 | 1/20 | 0.41 |
| ▸ | MEN1 | O00255 | 1/20 | 0.41 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.41 |
| ▸ | MAPT | P10636 | 1/20 | 0.41 |
| ▸ | HTT | P42858 | 1/20 | 0.41 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.41 |
| ▸ | ATM | Q13315 | 1/20 | 0.41 |
| ▸ | POLH | Q9Y253 | 1/20 | 0.41 |
| ▸ | EGFR | P00533 | 3/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4161329 | 1.00 | ADORA3 (0.47) | ADORA3ABCB1ELANEALOX5FFAR1 | |
| SCHEMBL4164241 | 1.00 | ADORA3 (0.47) | ADORA3ABCB1ELANEALOX5FFAR1 | |
| SCHEMBL4169488 | 0.99 | ADORA3 (0.48) | ADORA3ABCB1ELANEALOX5FFAR1 | |
| SCHEMBL4157369 | 0.92 | POLH (0.46) | ABCB1ELANEALOX5POLH | |
| SCHEMBL4165827 | 0.92 | POLH (0.46) | ABCB1ELANEALOX5POLH | |
| SCHEMBL4152386 | 0.92 | POLH (0.46) | ABCB1ELANEALOX5POLH | |
| SCHEMBL4165750 | 0.91 | POLH (0.47) | ABCB1ELANEALOX5POLH | |
| SCHEMBL4161068 | 0.86 | ABCB1 (0.63) | ADORA3ABCB1MEN1MAPTHTT | |
| SCHEMBL4163581 | 0.86 | ABCB1 (0.63) | ADORA3ABCB1MEN1MAPTHTT | |
| SCHEMBL4166839 | 0.86 | ABCB1 (0.63) | ADORA3ABCB1MEN1MAPTHTT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20090130051-A1 | Flavonoid Compounds and Uses Thereof | HOWARD FLOREY INSTITUTE OF EXPERIMENTAL PHYSIOLOGY AND MEDICINE (AU) | 2009-05-21 | — | — | US | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20090130051-A1 | Flavonoid Compounds and Uses Thereof | CAT, NQO1, GPX4 | ADORA3 2776/4885ABCB1 1605/4885ELANE 742/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.